Although IM alone also reduced the frequency of CML-KLS+ cells, the combined administration of IM plus cefadroxil had a much greater repressive effect on this population (Fig. 6e; Supplementary Fig. 12). Here, RPS6KB2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.